← United States · Coverage record
US · SEC FORM 4
BeOne Medicines Ltd.
ONC · Nasdaq; OTC · CIK 0001651308 · Healthcare · Biotechnology
INSIDER SIGNAL
0 qualifying P purchase groups
in the current 180-day scoring window
196 Form 4 transaction lines observed in the same window
154 sales · 42 option, withholding, award, gift or other lines
WHY NO ACTIVE SIGNAL?
Score anatomy
No score is calculated because there is no qualifying purchase in the active window. Unavailable inputs are not treated as zero or as a bearish signal.
Why is there no score?
- No qualifying open-market purchase supplies cluster, size, role, recency or conviction inputs.
- Sales and other Form 4 activity remain visible as context and do not create a negative score.
Sales and other Form 4 activity are shown separately and do not create a negative buy signal. Absence of buying is not scored as bearish.
Insider activity timeline
Owner lanes show the latest 180 days. Symbol shape identifies the transaction type; sales remain context only.
Showing the six most active owners; 5 additional owner(s) remain in Form 4 evidence.
Purchase breadth, concentration & cluster buying
These modules activate when qualifying purchases enter the 180-day research window.
SIGNAL HISTORY
Scores are archived only when the company qualifies for a published US buy-signal snapshot. Last qualifying purchase: 2021-09-10 · AMGEN INC.
Recent Form 4 activity
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
Market context
Market context has not been captured for this ticker yet. The daily market-context job processes the US universe in rotating batches.
Short interest
Short interest is external context reported to FINRA by broker-dealers. It does not affect the Insider Signal.
- Shares short
- 1,933,092
- Previous report
- 1,707,474
- Avg daily volume
- 389,451
- Days to cover
- 5.0
FINRA settlement date: 2026-09-30 · Captured 2026-10-12 · FINRA equity short interest ↗. A share count, published about a week after each of two settlement dates a month; not a percentage of shares outstanding.
Historical equity purchases
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
| Transaction date | Reporting owner | Type | Security | Shares | Avg. price | Approx. value | Source |
|---|---|---|---|---|---|---|---|
| 2021-09-10 | AMGEN INC | Purchase (P) | American Depositary Shares | 165,529 | USD 302.06 | USD 49,999,690 | SEC filing ↗ |
Form 4 evidence
280 transaction lines in the latest 365-day window; 1,627 in local history.
| Date | Owner | Type | Security | Shares | Avg. price | Approx. value | Source |
|---|---|---|---|---|---|---|---|
| 2026-10-13 | Wang Xiaodong | Sale (S) | American Depositary Shares | 31,027 | USD 350.99 | USD 10,890,074 | SEC filing ↗ |
| 2026-10-13 | Wang Xiaodong | Option exercise / conversion (M) | American Depositary Shares | 31,027 | USD 36.90 | USD 1,144,896 | SEC filing ↗ |
| 2026-09-30 | Lee Chan Henry | Sale (S) | American Depositary Shares | 1,115 | USD 375.00 | USD 418,125 | SEC filing ↗ |
Show recent Form 4 evidence (30 grouped rows)
| Date | Owner | Type | Security | Shares | Avg. price | Approx. value | Source |
|---|---|---|---|---|---|---|---|
| 2026-10-13 | Wang Xiaodong | Sale (S) | American Depositary Shares | 31,027 | USD 350.99 | USD 10,890,074 | SEC filing ↗ |
| 2026-10-13 | Wang Xiaodong | Option exercise / conversion (M) | American Depositary Shares | 31,027 | USD 36.90 | USD 1,144,896 | SEC filing ↗ |
| 2026-09-30 | Lee Chan Henry | Sale (S) | American Depositary Shares | 1,115 | USD 375.00 | USD 418,125 | SEC filing ↗ |
| 2026-09-28 | Wang Xiaodong | Sale (S) | American Depositary Shares | 31,028 | USD 364.79 | USD 11,318,606 | SEC filing ↗ |
| 2026-09-28 | Wang Xiaodong | Option exercise / conversion (M) | American Depositary Shares | 31,028 | USD 36.90 | USD 1,144,933 | SEC filing ↗ |
| 2026-09-14 | 667, L.P.; BAKER BROS. ADVISORS LP; BAKER FELIX; BAKER JULIAN; Baker Bros. Advisors (GP) LLC; Baker Brothers Life Sciences LP | Option exercise / conversion (M) | American Depositary Shares | 30,768 | USD 36.83 | USD 1,133,185 | SEC filing ↗ |
| 2026-09-08 | Wang Xiaodong | Sale (S) | American Depositary Shares | 38,287 | USD 349.10 | USD 13,365,964 | SEC filing ↗ |
| 2026-09-08 | Wang Xiaodong | Option exercise / conversion (M) | American Depositary Shares | 31,027 | USD 36.90 | USD 1,144,896 | SEC filing ↗ |
| 2026-09-01 | Ball Titus B. | Sale (S) | American Depositary Shares | 132 | USD 355.86 | USD 46,974 | SEC filing ↗ |
| 2026-08-25 | Wu Xiaobin | Sale (S) | American Depositary Shares | 280 | USD 380.00 | USD 106,400 | SEC filing ↗ |
| 2026-08-12 | OYLER JOHN | Sale (S) | American Depositary Shares | 54,892 | USD 358.15 | USD 19,659,540 | SEC filing ↗ |
| 2026-08-11 | Lee Chan Henry | Sale (S) | American Depositary Shares | 2,666 | USD 360.00 | USD 959,760 | SEC filing ↗ |
| 2026-08-11 | Lee Chan Henry | Option exercise / conversion (M) | American Depositary Shares | 2,666 | USD 191.37 | USD 510,190 | SEC filing ↗ |
| 2026-08-11 | OYLER JOHN | Sale (S) | American Depositary Shares | 70,907 | USD 361.90 | USD 25,661,365 | SEC filing ↗ |
| 2026-08-10 | OYLER JOHN | Sale (S) | American Depositary Shares | 115,011 | USD 357.88 | USD 41,159,726 | SEC filing ↗ |
| 2026-08-03 | Rosenberg Aaron | Sale (S) | American Depositary Shares | 1,157 | USD 312.72 | USD 361,817 | SEC filing ↗ |
| 2026-07-30 | Lee Chan Henry | Sale (S) | American Depositary Shares | 1,044 | USD 323.69 | USD 337,932 | SEC filing ↗ |
| 2026-07-22 | Lee Chan Henry | Sale (S) | American Depositary Shares | 1,669 | USD 325.00 | USD 542,425 | SEC filing ↗ |
| 2026-07-22 | Lee Chan Henry | Option exercise / conversion (M) | American Depositary Shares | 1,669 | USD 191.58 | USD 319,740 | SEC filing ↗ |
| 2026-07-21 | OYLER JOHN | Sale (S) | American Depositary Shares | 61,397 | USD 317.67 | USD 19,504,082 | SEC filing ↗ |
| 2026-07-20 | OYLER JOHN | Sale (S) | American Depositary Shares | 48,316 | USD 312.26 | USD 15,086,929 | SEC filing ↗ |
| 2026-07-20 | OYLER JOHN | Option exercise / conversion (M) | American Depositary Shares | 33,990 | USD 119.96 | USD 4,077,440 | SEC filing ↗ |
| 2026-07-17 | OYLER JOHN | Sale (S) | American Depositary Shares | 64,628 | USD 312.00 | USD 20,163,749 | SEC filing ↗ |
| 2026-07-17 | OYLER JOHN | Option exercise / conversion (M) | American Depositary Shares | 64,628 | USD 119.96 | USD 7,752,775 | SEC filing ↗ |
| 2026-07-16 | OYLER JOHN | Sale (S) | American Depositary Shares | 166,597 | USD 318.09 | USD 52,992,334 | SEC filing ↗ |
| 2026-07-16 | OYLER JOHN | Option exercise / conversion (M) | American Depositary Shares | 166,597 | USD 143.38 | USD 23,887,477 | SEC filing ↗ |
| 2026-07-15 | OYLER JOHN | Sale (S) | American Depositary Shares | 116,557 | USD 311.94 | USD 36,359,316 | SEC filing ↗ |
| 2026-07-15 | OYLER JOHN | Option exercise / conversion (M) | American Depositary Shares | 116,557 | USD 148.00 | USD 17,250,520 | SEC filing ↗ |
| 2026-07-14 | OYLER JOHN | Sale (S) | American Depositary Shares | 145,861 | USD 305.95 | USD 44,626,082 | SEC filing ↗ |
| 2026-07-14 | OYLER JOHN | Option exercise / conversion (M) | American Depositary Shares | 133,600 | USD 54.06 | USD 7,222,959 | SEC filing ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
Snapshot & identity
| Snapshot date | 2026-10-18 |
|---|---|
| Ranking version | US-v1.2 |
| Data quality | PASS ELIGIBLE · — |
| Ticker | ONC |
| CIK | 0001651308 |
| Sector | Healthcare |
| Industry | Biotechnology Yahoo Finance |
| SEC SIC | 2834 Pharmaceutical Preparations |
| Exchange | Nasdaq; OTC |
Data coverage
| Local Form 4 history | 1,627 transaction lines from 2020-01-21 to 2026-10-13 1 P purchase lines · 1,335 S sale lines · 291 other lines |
|---|---|
| SEC company submissions | Open SEC filings ↗ |
Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.